Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma

Authors: Camus, Vincent ^{1, 2, ∗}, Molina, Thierry ³, Desmots, Fabienne ⁴, Blanc-Durand, Paul ⁵, Kanoun, Salim ⁶, Moslemi, Amine ⁷, Ruminy, Philippe ², Le Gouill, Steven ⁸, Ghesquières, Hervé ⁹, Oberic, Lucie ¹⁰, Morschhauser, Franck ¹¹, Tilly, Hervé ^{1, 2}, Ribrag, Vincent ¹², Houot, Roch ¹³, Thieblemont, Catherine ¹⁴, Maisonneuve, Hervé ¹⁵, Claves, Fabien ¹⁶, Bouabdallah, Krimo ¹⁷, Haioun, Corinne ¹⁸, Damaj, Gandhi Laurent ¹⁹, Fornecker, Luc-Matthieu ²⁰, Noel, Robin ²¹, Feugier, Pierre ²², Sibon, David ²³, Cartron, Guillaume ²⁴, Bonnet, Christophe ²⁵, Bernard, Wivine ²⁶, Kraeber-Bodéré, Françoise ²⁷, Bodet-Milin, Caroline ²⁷, Jais, Jean-Philippe ²⁸, Brière, Josette ²⁹, Rossi, Cedric ³⁰, Elsensohn, Mad-Hélénie ³¹, Chartier, Loïc ³¹, Itti, Emmanuel ⁵, Jardin, Fabrice ^{1, 2}, Fest, Thierry ⁴

Source: In Blood Advances 13 May 2025 9(9):2232-2246

Efficacy of tazemetostat in combination with R-CHOP in elderly patients newly diagnosed with diffuse large B cell lymphoma: results of the EpiRCHOP phase II study of the LYSA

Authors: Sarkozy, Clémentine ^{a, b, ∗}, Molina, Thierry Jo ^c, Dubois, Sydney ^d, Portugues, Cédric ^e, Bohers, Elodie ^f, Ysebaert, Loic ^g, Houot, Roch ^h, Pica, Gian Matteo ⁱ, Ruminy, Philippe ^f, Herbaux, Charles ^j, Gastinne, Thomas ^k, Thieblemont, Catherine ^l, Haioun, Corinne ^m, Guidez, Stéphanie ⁿ, Bonnet, Christophe ^o, Crochet, Gilles ^p, Veresezan, Liana ^q, Choquet, Sylvain ^r, Bachy, Emmanuel ^s, Jardin, Fabrice ^t, Morschhauser, Franck ^u, Ribrag, Vincent ^v

Source: In eClinicalMedicine April 2025 82

A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies

Authors: Ribrag, Vincent ^{a, ⁎}, Iglesias, Lara ^b, De Braud, Filippo ^c, Ma, Brigette ^d, Yokota, Tomoya ^e, Zander, Thomas ^f, Spreafico, Anna ^g, Subbiah, Vivek ^h, Illert, Anna L. ^{i, j, k, l}, Tan, Daniel ^m, Santoro, Armando ⁿ, Munster, Pamela N. ^o, Suehiro, Youko ^p, Wang, Yongsheng ^q, Ji, Dong-Mei ^{r, s}, Chen, Shuqi ^t, Beltz, Karen ^u, Suenaga, Naoko ^v, Ramkumar, Thiruvamoor ^w, Luo, Fangjun ^t, Lai, Clinton ^t, Wainberg, Zev A. ^x

Source: In European Journal of Cancer 5 February 2025 216

Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet

Authors: Ribrag, Vincent ^{a, b, *}, Bron, Dominique ^c, Rymkiewicz, Grzegorz ^d, Hoelzer, Dieter ^f, Jørgensen, Judit ^g, de Armas-Castellano, Aythami ^h, Trujillo-Martín, Maria ^{h, i}, Fenaux, Pierre ^{j, k}, Malcovati, Luca ^{l, m}, Bolaños, Natacha ⁿ, Ribera, Josep-Maria ^o, Herbaux, Charles ^p, Sarkozy, Clémentine ^q, Zinzani, Pier Luigi ^r, Walewski, Jan ^e, Chamuleau, Martine E D ^s

Source: In The Lancet Haematology February 2025 12(2):e138-e150

Allogeneic Stem Cell Transplantation in Participants With Hematologic Malignancies Following Pembrolizumab Therapy

Authors: Kuruvilla, John ^{1, ⁎}, Armand, Philippe ², Herrera, Alex F. ³, Ribrag, Vincent ⁴, Thieblemont, Catherine ⁵, von Tresckow, Bastian ^{6, 7}, Wang, Guoqing ⁸, Marinello, Patricia ⁸, Chakraborty, Samhita ⁸, Orlowski, Robert ⁸, Zinzani, Pier Luigi ^{9, 10}

Source: In Transplantation and Cellular Therapy February 2025

Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience

Authors: Parisi, Claudia, Benitez, José Carlos, Lecourt, Hélène, dall’Olio, Filippo Gustavo, Aldea, Mihaela, Blanc-Durand, Felix, Vergé, Véronique, Quivoron, Cyril, Naltet, Charles, Abdayem, Pamela, Lavaud, Pernelle, Ghigna, Maria Rosa, Friboulet, Luc, Loriot, Yohann, De Botton, Stéphane, Ribrag, Vincent, Ardizzoni, Andrea, Planchard, David, Soria, Jean-Charles, Barlesi, Fabrice, Besse, Benjamin

Source: In The Journal of Liquid Biopsy December 2024 6

Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis

Authors: Gerds, Aaron T., Harrison, Claire, Kiladjian, Jean-Jacques, Mesa, Ruben, Vannucchi, Alessandro M., Komrokji, Rami, Bose, Prithviraj, Kremyanskaya, Marina, Mead, Adam J., Gotlib, Jason, Rose, Shelonitda, Sanabria, Fabian, Marsousi, Niloufar, Giuseppi, Ana Carolina, Jiang, Huijing, Palmer, Jeanne M., McCaul, Kelly, Ribrag, Vincent, Passamonti, Francesco

Source: In Blood Advances 10 September 2024 8(17):4511-4522

Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma

Authors: Sarkozy, Clémentine, Callanan, Mary, Thieblemont, Catherine, Obéric, Lucie, Burroni, Barbara, Bouabdallah, Krimo, Damaj, Gandhi, Tessoulin, Benoit, Ribrag, Vincent, Houot, Roch, Morschhauser, Franck, Griolet, Samuel, Joubert, Clémentine, Cacheux, Victoria, Delwail, Vincent, Safar, Violaine, Gressin, Remy, Cheminant, Morgane, Delfau-Larue, Marie-Hélène, Hermine, Olivier, Macintyre, Elizabeth, Le Gouill, Steven

Source: In Blood 18 July 2024 144(3):262-271

Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review

Authors: Géraud, Arthur, Hueso, Thomas, Laparra, Ariane, Bige, Naike, Ouali, Kaissa, Cauquil, Cécile, Stoclin, Annabelle, Danlos, François-Xavier, Hollebecque, Antoine, Ribrag, Vincent, Gazzah, Anas, Goldschmidt, Vincent, Baldini, Capucine, Suzzoni, Steve, Bahleda, Rastislav, Besse, Benjamin, Barlesi, Fabrice, Lambotte, Olivier, Massard, Christophe, Marabelle, Aurélien, Castilla-Llorente, Cristina, Champiat, Stéphane, Michot, Jean-Marie

Source: In European Journal of Cancer July 2024 205

Antibody drug conjugates in older patients: State of the art

Authors: Rached, Layal, Geraud, Arthur, Frelaut, Maxime, AP Thomas, Zoe, Goldschmidt, Vincent, Beraud-Chaulet, Geoffroy, Nagera-Lazarovici, Celine, Danlos, Francois-Xavier, Henon, Clemence, Parisi, Claudia, Gazzah, Anas, Bahleda, Rastilav, Postel Vinay, Sophie, Smolenschi, Cristina, Hollebecque, Antoine, Michot, Jean-Marie, Ribrag, Vincent, Loriot, Yohann, Champiat, Stephane, Ouali, Kaissa, Massard, Christophe, Ponce Aix, Santiago, Bringuier, Michael, Baldini, Capucine

Source: In Critical Reviews in Oncology / Hematology January 2024 193

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

Authors: Armand, Philippe, Zinzani, Pier Luigi, Lee, Hun Ju, Johnson, Nathalie A., Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P., Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A., Herrera, Alex F., Lin, Jianxin, Kim, Eunhee, Chakraborty, Samhita, Marinello, Patricia, Moskowitz, Craig H.

Source: In Blood 7 September 2023 142(10):878-886

Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study

Authors: Zinzani, Pier Luigi, Trněný, Marek, Ribrag, Vincent, Zilioli, Vittorio Ruggero, Walewski, Jan, Christensen, Jacob Haaber, Delwail, Vincent, Rodriguez, Guillermo, Venugopal, Parameswaran, Coleman, Morton, Dartigeas, Caroline, Patti, Caterina, Pane, Fabrizio, Jurczak, Wojciech, Taszner, Michal, Paneesha, Shankara, Zheng, Fred, DeMarini, Douglas J., Jiang, Wei, Gilmartin, Aidan, Mehta, Amitkumar

Source: In eClinicalMedicine August 2023 62

Profile and outcome of cancer patients enrolled in contemporary phase I trials

Authors: Alouani, Emily, Gazzah, Anas, Mercier, Sandrine, Bahleda, Ratislav, Hollebecque, Antoine, Michot, Jean-Marie, Baldini, Capucine, Ammari, Samy, Champiat, Stephane, Marabelle, Aurelien, Postel-Vinay, Sophie, Ribrag, Vincent, Loriot, Yohann, Aix, Santiago Ponce, Mahjoubi, Linda

Source: In European Journal of Cancer July 2023 188:1-7

Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma

Authors: Schjesvold, Fredrik, Paiva, Bruno, Ribrag, Vincent, Rodriguez-Otero, Paula, San-Miguel, Jesus F., Robak, Pawel, Hansson, Markus, Onishi, Maika, Hamidi, Habib, Malhi, Vikram, Dail, Monique, Javery, Apurva, Ku, Grace, Raab, Marc S.

Source: In Clinical Lymphoma, Myeloma and Leukemia January 2023 23(1):e59-e70

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Authors: Sarkozy, Clémentine, Chartier, Loïc, Ribrag, Vincent, Gressin, Remy, Geisler, Christian H., Kluin-Nelemans, Hanneke C., Thieblemont, Catherine, Morschhauser, Franck, Lemonnier, François, Safar, Violaine, Tessoulin, Benoît, Oberic, Lucie, Damaj, Ghandi, Ghesquières, Hervé, Bouabdallah, Krimo, Casasnovas, René Olivier, Houot, Roch, Klapper, Wolfram, Burroni, Barbara, Pott, Christiane

Source: Blood Cancer Journal; 4/24/2025, Vol. 15 Issue 1, p1-7, 7p

Mantle cell lymphoma: what clinical progress in the last 5 years?

Authors: Soueidy, Charbel, Michot, Jean-Marie, Ribrag, Vincent

Source: Expert Opinion on Investigational Drugs; Mar2025, Vol. 34 Issue 3, p131-147, 17p

Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study

Authors: Palomba, Maria Lia, Cartron, Guillaume, Popplewell, Leslie, Ribrag, Vincent, Westin, Jason, Huw, Ling-Yuh, Agarwal, Shefali, Shivhare, Mahesh, Hong, Wan-Jen, Raval, Aparna, Chang, Alice C., Penuel, Elicia, Morschhauser, Franck

Source: In Clinical Lymphoma, Myeloma and Leukemia July 2022 22(7):504-512

A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Authors: Ribrag, Vincent, Lee, Seung Tae, Rizzieri, David, Dyer, Martin J.S., Fayad, Luis, Kurzrock, Razelle, Andritsos, Leslie, Bouabdallah, Reda, Hayat, Amjad, Bacon, Larry, Jiang, Yu, Miah, Kowser, Delafont, Bruno, Hamid, Oday, Anyanwu, Stephanie, Martinez, Pablo, Hess, Brian

Source: In Clinical Lymphoma, Myeloma and Leukemia May 2021 21(5):309-317

Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA

Authors: Le Gouill, Steven ^{*, **}, Ghesquières, Hervé, Oberic, Lucie, Morschhauser, Franck, Tilly, Hervé, Ribrag, Vincent, Lamy, Thierry, Thieblemont, Catherine, Maisonneuve, Hervé, Gressin, Rémy, Bouhabdallah, Krimo, Haioun, Corinne, Damaj, Gandhi, Fornecker, Luc, Bouhabdallah, Réda, Feugier, Pierre, Sibon, David, Cartron, Guillaume, Bonnet, Christophe, André, Marc, Chartier, Loic, Ruminy, Philippe, Kraeber-Bodéré, Françoise, Bodet-Milin, Caroline, Berriolo-Riedinger, Alina, Brière, Josette, Jais, Jean-Philippe, Molina, Thierry Jo, Itti, Emmanuel, Casasnovas, René-Olivier ^{*, *}

Source: In Blood 29 April 2021 137(17):2307-2320

Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma

Authors: El Halabi, Layal, Adam, Julien, Gravelle, Pauline, Marty, Virginie, Danu, Alina, Lazarovici, Julien, Ribrag, Vincent, Bosq, Jacques, Camara-Clayette, Valérie, Laurent, Camille, Ghez, David

Source: In Clinical Lymphoma, Myeloma and Leukemia April 2021 21(4):257-266